Heart Failure Pharmacology
Sort by:
Heart Failure 2021: An Update on Therapy
Use of Diuretics in Patients With Volume Overload: What to Do When You See Diuretic Resistance?
FEATURING
Jeffrey Testani
- 643 views
- March 30, 2021
- 11
NYU Langone
Emerging Therapies in Cardiac Amyloidosis
FEATURING
Mazen Hanna
- 790 views
- June 8, 2022
- 13
Georgia Heart Institute
Heart Failure Therapies
FEATURING
Ugochukwu Egolum,
Habib Samady
- 52 views
- November 8, 2022
- 1
Scripps Health
Heart Failure with Preserved Ejection Fraction: New Treatments
FEATURING
Rajeev C. Mohan
- 727 views
- June 13, 2023
- 10
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians
Recognizing and Treating HFpEF: How Helpful Are MRAs, ARNi and SGLT2 Inhibitors for Treating Patients? What Have We Learned From The PARADIGM and PARAGON Trials?
FEATURING
Barry Greenberg
- 2,010 views
- February 5, 2021
- 22
Northwestern Medicine: 8th Annual Cardiovascular Update
AF and Heart Failure: What’s the Risk? Is Ablation the Answer?
FEATURING
Jonathan Piccini
- 686 views
- August 14, 2019
- 11
26th Annual San Diego Heart Failure Symposium
Broadening Indications for the Use of Angiotensin Receptor Neprilysin Inhibitors in Patients with HFrEF, ADHF and HFpEF
FEATURING
Clyde Yancy
- 1,027 views
- December 16, 2020
- 15
16th Annual Mid-Atlantic Hospital Medicine Symposium
Acute Heart Failure and Knowing Medications
FEATURING
Anuradha Lala-Trindade
- 1,243 views
- December 15, 2021
- 17
American College of Cardiology
ESC Congress 2022: DANCAVAS, REVIVED-BCIS2, ADVOR, ALL-HEART, and DELIVER Trials
- 348 views
- September 20, 2022
- 5
The Texas Heart Institute
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure
FEATURING
Biykem Bozkurt
- 1,678 views
- February 8, 2023
- 19
AHA 2023 Insights
AHA 2023 Insights: Optimizing the Use of SGLT2is, GLP-1 RAs and Non-Steroidal MRAs for Multi-System Benefit
FEATURING
Faiez Zannad
- 1,706 views
- November 21, 2023
- 19
ACC 2024 Insights
ACC 2024 Insights: Evolving Pharmacology for HFrEF vs. HFpFF - With or Without Chronic Kidney Disease and/or Diabetes
FEATURING
Maria Costanzo
- 1,385 views
- April 16, 2024
- 18
The Texas Heart Institute
Inside the Studio with Drs. Joseph Rogers and Carolyn Lam - HFpEF
FEATURING
Joseph Rogers,
Carolyn S. P. Lam
- 55 views
- January 5, 2023
- 1
Terumo Interventional Systems
Re-thinking Patient-Centered Care in Cardiology-Heart Failure Evaluation in Emergency Dept.
FEATURING
John Spertus
- 172 views
- July 14, 2021
- 1
ACHL
Treatment of Iron Deficiency Across the Heart Failure Spectrum
FEATURING
Stormi Gale
- 723 views
- December 7, 2023
- 10
Scripps Health
Best Practices in Managing Cardiac Toxicity in the Breast Cancer Patient: The Cardiologist's Perspective - a 2022 Update
FEATURING
Margot Davis
- 56 views
- October 18, 2022
- 1
13th Orange County Symposium for Cardiovascular Disease Prevention
SGLT2 inhibitors and GLP-1 agonists: Why Are They Important and Which Do I Choose?
FEATURING
Yehuda Handelsman
- 3,406 views
- January 27, 2022
- 15
13th Annual Winter Breast Cancer Symposium
Cardiovascular Toxicity and Breast Cancer: Detection and Prevention Strategies
FEATURING
Paaladinesh Thavendiranathan
- 114 views
- February 28, 2023
- 2
Piedmont Heart Institute
Cardiometabolic Therapies: GLP-1 RAs and SGLT-2i
FEATURING
Jaime Burkle
- 1,738 views
- January 25, 2022
- 18